We understand that your staff and organization focus their time on the most important aspect of treatment – patients.

Identifying patients with relapsed or refractory multiple myeloma (RRMM) who may be eligible for a bispecific therapy

Patient queries (also referred to as “patient lists” and “reports”) in the electronic health record (EHR) can be leveraged to identify patients with potential care gaps. Consider conducting a patient query to help identify patients diagnosed with RRMM who have already received at least 4 lines of treatment or are currently receiving fourth-line treatment and may be candidates for fifth-line treatment, and thus may be eligible for a bispecific therapy.

Informational publication

Article outlining recommendations from a panel of academic and community practice pharmacists with experience using bispecific antibodies in clinical trials and standard of care:

Seamless Navigation of Bispecific Therapies: Optimizing Management and Outpatient Access With a Focus on Coordination